Out of the 161 genes involved in enriched pathways between BD and FS found in this study, 129 (80%) were found to be differentially expressed in breast cancer (Fig. 3), including significantly higher expression of Runx2 and Skp2 in both the BD and breast cancer groups (Table S2). This evidence concerns the gene RUNX2 and breast carcinoma.